Patient Access to Urgent-Use Pharmacy Compounding Act of 2023

Cost and committee reports

Official records Congress.gov attaches to H.R. 167.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mr. GRIFFITH, as printed in the Congressional Record (Vol. 169, No. 7, January 9, 2023, Page H111):
  This bill is enacted pursuant to the power granted to Congress under Article I, Section 8 of the United States Constitution
  Source: Congress.gov, Congressional Record January 9, 2023 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  123 characters

  Congress.gov bill record

  H.R. 167, 118th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/118/hr/167

  Record last updated by Congress.gov

  May 27, 2025

  PORKER copy retrieved

  September 14, 2026

  Stored copy, SHA-256 of the file

  95bbd6e7496160b073f0f28ecbd170fdebb3f28a6774ddf2b72499f3f4610cfc

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of May 27, 2025). Not every bill gets one.

From the Congress.gov bill record for H.R. 167, last updated May 27, 2025. PORKER’s copy was retrieved September 14, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.